Atrium Therapeutics, Inc. (RNA)
13.29
-0.01
(-0.08%)
USD |
NASDAQ |
May 14, 16:00
13.29
0.00 (0.00%)
After-Hours: 18:47
Atrium Therapeutics EPS Diluted (Quarterly) : -1.702 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| KalVista Pharmaceuticals, Inc. | -0.1055 |
| Intellia Therapeutics, Inc. | -0.8121 |
| Recursion Pharmaceuticals, Inc. | -0.222 |
| Tango Therapeutics, Inc. | -0.2945 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.14M |
| Revenue (Quarterly) | 0.859M |
| Total Expenses (Quarterly) | 30.00M |
| Enterprise Value | 210.02M |
| Gross Profit Margin (Quarterly) | 85.80% |
| Profit Margin (Quarterly) | -3.39K% |
| Earnings Yield | -17.87% |